It is increasingly recognized that while each rare disease may affect a small number of individuals the collective burden of rare or orphan diseases is a major global healthcare challenge. The World Economic Forum estimates that 475 million people worldwide are affected by a rare disease. To mark World Rare Disease Day (28 February 2021), in this article Stephanie Finnegan, Cromos Pharma’s COO, explores the opportunities and challenges for rare disease drug development. Read the full paper here.
To arrange an introductory meeting and find out how our experience can benefit your next clinical project.